The program covers critical subjects such as progress cell gene therapy manufacturing, ATMP development, scale-up and scale-out, manufacturing data, R&D, CAR-T therapies, global regulatory affairs, stem cells, cord blood, pricing & reimbursement, improving cost efficiency, commercialization, and how to leverage innovation to convert research to advance cell gene therapy manufacturing.
Back to All Events
Earlier Event: January 28
Workshop on Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies
Later Event: February 6
Regenerative Medicine Crossroad in Tokyo #11 (RMCR#11)